Using quarterly earnings to assess racing performance in 70 thoroughbreds after modified laryngoplasty for treatment of recurrent laryngeal neuropathy.
Authors: Aceto Helen, Parente Eric J
Journal: Veterinary surgery : VS
Summary
# Editorial Summary: Modified Laryngoplasty and Racing Performance in Thoroughbreds Modified laryngoplasty successfully restores racing competitiveness in Thoroughbreds affected by recurrent laryngeal neuropathy, with horses returning to performance levels comparable to unaffected cohorts within six months of surgery. This retrospective analysis of 70 treated horses and 210 untreated controls tracked quarterly earnings and race starts over multiple years, finding that whilst treated horses performed significantly worse in their final pre-surgery race (P < 0.001)—validating the baseline impairment—they showed no meaningful differences in race participation or earnings from the second quarter onwards. All operated horses returned to racing, with cumulative survival rates up to 40 races matching their unaffected peers, demonstrating that the procedure does not predispose to premature retirement or career-limiting complications. These findings provide objective, longitudinal evidence that modified laryngoplasty offers a viable intervention for horses with this career-threatening condition, supporting its use when owners and trainers wish to maximise returning athletes' competitive lifespan. Quarterly earnings analysis proves a sensitive method for tracking functional recovery in performance horses, offering equine professionals a measurable framework for counselling clients on realistic post-operative expectations.
Read the full abstract on PubMed
Practical Takeaways
- •Modified laryngoplasty is effective for returning racehorses with recurrent laryngeal neuropathy to competitive performance levels within 6 months post-surgery
- •Expect a performance dip in the immediate post-operative period (first quarter), but horses typically recover to pre-disease performance by Q2
- •Long-term racing longevity appears unaffected by the surgery, supporting it as a viable treatment option for maintaining racing careers
Key Findings
- •Treated horses performed significantly worse than untreated horses in the race immediately before surgery (P < 0.001)
- •By the second quarter after modified laryngoplasty, treated horses showed no significant differences in race starts or earnings compared to untreated cohorts
- •All 70 treated horses returned to racing post-operatively with no difference in cumulative survival up to 40 races compared to untreated controls